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Abstract
Introduction This study investigated the relationship between serum 25-hydroxyvitamin D (25OHD) levels and the occurrence of hip fractures in the elderly using a systematic review and meta-analysis approach.
Materials and methods PubMed, Web of Science, and Scopus were used to identify studies that outlined an association
between serum 25OHD and the occurrence of a hip fracture in a geriatric patient. The analysis calculated odds ratios (OR)
for a hip fracture using a random-effects model.
Results In this study, 28 studies were included, 61,744 elderlies and 9767 cases (15.81%) of hip fractures. In the lowest
vs. highest categories of vitamin D in the elderly, pooled OR of hip fractures was 1.80 (95% CI 1.56–2.07, P ≤ 0.001), and
modified OR was equal to 1.40 (95% CI 1.20–1.63 P ≤ 0.001). A subgroup analysis showed that the OR of a hip fracture
was 2.16 (1.49–3.11, P ≤ 0.001) in case–control studies; 1.52 (1.29–1.79, P = 0.001) in cohort studies; and 1.41 (1.18–1.70,
P ≤ 0.001) in case–cohort studies.
Conclusion Low serum vitamin D levels in the elderly are associated with an increase in the odds of hip fracture.
Keywords Vitamin D · Vitamin D deficiency · Osteoporotic fractures · Hip · Aged · Elderly

Introduction
Vitamin D deficiency is one of the most common problems among elderlies in different countries around the
world that leads to referral to the rehabilitation unit [1–5].
Vitamin D insufficiency has been defined as a circulating
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serum 25-hydroxyvitamin D (25OHD) level < 20 ng/mL [6].
Some reference ranges outline that 75–175 nmol/L of serum
25OHD is the normal range, as provided by the Institute of
Medicine (IOM) [7, 8]. Low serum vitamin D levels are
associated with various metabolic and systemic disorders
[8, 9].
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Importantly, vitamin D has a crucial role in calcium
homeostasis and, subsequently, bone metabolism [10, 11].
In those with chronic vitamin D deficiency, it has been
observed that they have reduced phosphorus absorption, a
decline in intestinal calcium, which leads to hypocalcemia
and eventually secondary hyperparathyroidism [12, 13].
The continuation of secondary hyperparathyroidism is the
development of phosphaturia, which accelerates the decline
in renal function and precipitates bone demineralization
[14]. In people aged 60 years or older, the consequence of
low serum 25OHD is an increased potential risk of osteoporosis and osteoporotic hip fractures [15]. A hip fracture
in the elderly imposes additional health and social costs. It
impacts their ability to undertake activities of daily living
independently, leads to psychosocial problems, and a general
deterioration in their quality of life [16–19].
Aging is a special period of every person's life, in this
period; people may be forced to use certain dietary patterns
due to affecting various diseases (such as diabetes, hypertension, cardiovascular disease, cancer, etc.) [20, 21] or financial problems due to low income, which are less likely to
receive micronutrients [22]. On the other hand, these people
are at risk of bone fractures, especially hip fractures, due to
diseases such as osteoporosis or physical problems caused
by aging and as a result of the inability to maintain balance
[23, 24].
Although some previous meta-analysis studies show that
low serum 25 (OH) vitamin D level increases the risk of total
hip fractures [25, 26], another meta-analysis study showed
that vitamin D supplementation in the elderly did not have a
preventive effect on hip fractures at any of the administered
doses [27]. In addition, some other meta-analyses showed
that co-supplementation with calcium and vitamin D was
a more promising preventive strategy against hip fractures
[28]. Due to the inconsistencies in the results of the studies, the need for newer meta-analysis studies seems to be
necessary. On the other hand, despite recent observational
studies on the field, more robust evidence could be drawn
from this up-to-date meta-analysis to provide for the health
professionals and researchers. Therefore, due to the ambiguity in this relationship, this study aimed to explore the association between serum vitamin D levels and hip fractures
in the elderly using a systematic review and meta-analysis
approach.

Materials and methods
Data sources and search strategy
This meta-analysis was performed following PRISMA
guidelines (http://prisma-statement.org/prismastatement/
Check  l ist.  a spx). An extensive systematic review was
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undertaken on 8/8/2021 utilizing PubMed, Web of Science
(ISI), and Scopus databases. The following main and MeSH
keywords were used in the search: ((“serum 25-hydroxyvitamin D” OR “serum 25(OH)D” OR “serum vitamin
D”) AND (hip fracture*) AND (“elderly” OR “age” OR
“senile”)).

Study selection
The peer-reviewed publications were imported into EndNote
X8 (8 November 2016, Thomson Reuters), where the software was used to identified and remove duplications. Two
researchers independently evaluated the title and abstract
of the studies based on the defined inclusion and exclusion
criteria. To meet inclusion criteria, the studies had to have
investigated the association between serum vitamin D levels
and hip fractures. Exclusion criteria were applied when there
was no full text of the publication available, and the study
was in a non-English language. The study was excluded from
being reviewed when it included those less than 60 years of
age, involved supplementation with vitamin D, the study
population had disabilities or mal-absorption disease, and
bone diseases that could impact the final study outcome. The
full text of all publications with studies identified as matching the criteria was independently reviewed. If there were
any disagreements upon review, a consensus was achieved
through discussion with a third team member. A flowchart
of the search strategy is illustrated in Fig. 1.

Data extraction and quality assessment
Data were extracted independently by three individuals,
and inconsistencies were resolved through discussion. For
included studies, the following information was extracted:
the first author's name, year of publication, country of study,
sample size, age of study population, and duration of followup. Statistical information, including odds ratio (OR) or risk
ratio (RR) or Hazard Ratio (HR) with 95% confidence interval (CI) of hip fracture in lowest vs. highest categories of
vitamin D in the elderly.
A quality assessment scale, the Newcastle–Ottawa Scale
(NOS), was utilized to assess the quality of non-randomized
studies. Using the NOS, each study with a score range of 0–9
was assessed. Articles with a score range of 0–9 and articles
with a score of 6 ≤ were considered to be low risk of bias or
high-quality studies [29, 30].

Statistical analysis
For the meta-analysis, the odds ratio (OR) was used to
assess the relationship of hip fracture with serum vitamin
D levels. The effect size of the relationship between serum
vitamin D levels and hip fracture was reported by OR with
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Fig. 1  Flowchart of selection
studies for inclusion in the
meta-analysis
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Screening

Identification

Identification of studies via databases and registers

Records identified from
Databases (n = 855)
PubMed: 191
Web of Science: 412
Scopus: 252
Registers (n = 0)

Records removed before
screening:
Duplicate records removed (n
= 590)
Records marked as ineligible
by automation tools (n = 0)
Records removed for other
reasons (n = 63)

Records screened
(n = 202)

Records excluded
(n = 158)

Reports assessed for eligibility
(n = 44)

Reports excluded: 18
Non English language (n = 2)
Without control group (n = 3)
No desire indicators (n=8)
Irrelevant purpose of study
(n=4)
Reports not retrieved (n=1)

Included

Additional articles identified
through references of previous
meta-analysis (n= 2)
Studies included in review
(n = 28)
Reports of included studies
(n = 0)

a 95% confidence interval (CI). The method of randomeffects models of the meta-analysis was used to calculate
the overall summary estimates. Graphically, the illustration of the individual OR and summary estimates was done
in the form of forest plots. Based on a priori decisions,
subgroup analyses were conducted according to the geographical location (Europe, America, Asia, and Australia),
study quality (low vs. high quality), the sample size for
study (˃ 1000 vs. ≤ 1000), and type of study (case–control,
case–cohort and cohort), gender (male, female and both),
study period (1998–2010 and 2011–2021), and the followup period (> 5 years or ≤ 5 years). To reveal more clearly
the sources of statistical heterogeneity between studies, as
well as to evaluate the robustness of the findings, a series
of sensitivity analyses were performed. First, we aimed to
examine the effect of individual studies on the summary
estimates, for which influence analyses were conducted
where the pooled estimates were recalculated by omitting
one study at a time. Second, a meta-regression analysis

was conducted to identify the source of differences in the
observed effect size between studies.
Heterogeneity among studies was tested by Cochran’s Q
test (reported with a χ2 value and P value, with P < 0.1 considered as the significance level) and the I2 statistics. I2 with
values of 25%, 50%, and 75% demonstrated low, moderate, and
high levels of heterogeneity, respectively. Publication bias was
assessed using Begg’s and Egger’s tests. Metatarium command
was used to estimate the effect size of relation in the missing
studies. All statistical analyses were performed using Stata
14.0 software (Stata LLC, College Station, TX, USA). P < 0.05
was considered as the level of significance.
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Results
Search results, study characteristics of selected
studies
The PRISMA statement flowchart of the search strategy is
illustrated in Fig. 1. The initial electronic search retrieved
855 titles/abstracts. Omission of duplicate publications was
590 excluded and 63 removed for other reasons, leaving 202
titles/abstracts to be screened. After reviewing the remaining
titles and abstracts, 158 articles unrelated to this study focus
were excluded, leaving 44 to be retrieved for more in-depth
screening. Additional titles/abstracts were excluded (n = 18);
two because the publication was not available in English [31,
32], one as there was no full text available [33], four that were
not related to the rationale of this study [34–37], three not
undertaken in people with hip fractures (and did not include
a control group) [38–40] and eight which had not calculated
the desired indicators [15, 41–47]. Finally, 26 articles were
selected for the final assessment of the association between
serum vitamin D levels and the risk of hip fractures in the
current systematic review and meta-analysis, and 2 other additional records were found through searching in previous metaanalyses [14, 48–74].

Characteristics of selected studies
regarding the association between serum vitamin D
levels and the risk of hip fractures
The 28 studies that were reviewed included 61,744 participants
who met the inclusion criteria. There were 9767 (15.81%)
cases that reported hip fractures [14, 48–74]. Among the studies included, four used a case–cohort design with a sample size
of 5492 participants and 1631 (29.69%) cases of hip fracture
[48–51], fifteen were cohort studies, with a sample size of
49,860 participants and 6617 (13.27%) cases of hip fracture
[52–66], and nine studies used a case–control design with a
sample size of 6392 participants and 1519 (23.76%) cases of
hip fracture [14, 67–74] (Tables 1–3).
The articles selected for this systematic review and metaanalysis were published between 1998 and 2020. The studies were geographically diverse, with eleven conducted in the
North America [48, 50–53, 56–58, 61, 70], six in Europe [49,
60, 62–65], seven in Asia [55, 59, 68, 69, 71, 73, 74], three
in Australia [54, 66, 67], one in Brazil [14] and finally, one
undertaken in Canada [72]. The mean follow-up of the participant’s period was 69.64 months (Tables 1–3).
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Relationship between serum vitamin D levels
and hip fractures
Considering the adjusted odds ratios (OR) (Table 2) from
each study in the meta-analysis, it is observed that compared to the group with high levels of serum vitamin D,
the OR of hip fractures in the elderly with low levels is
equal to 1.80 (95% CI 1.56–2.07, P ≤ 0.001) (Fig. 2).
There was significant heterogeneity identified within
the results during the meta-analysis (chi2 = 86.64, df = 27,
P ≤ 0.001, I2 = 68.8%). A meta-regression was performed
and included assessing the following variables: year, follow-up term, study type/design, gender, sample size, quality of study based on the Newcastle–Ottawa Scale (NOS),
study period, and geographical location. The results from
the meta-regression analysis determined there was no significant source of heterogeneity (P > 0.10). Also, sensitivity analysis was performed by excluding each study from
the analysis one by one during each run. However, the
estimated OR did not change significantly, further indicating the robustness of the meta-analysis results.

Evaluation of publication bias related to serum
vitamin D levels and hip fractures
Evidence of publication bias was suspected upon examining the reported association between serum vitamin D
levels and hip fracture. To investigate this, statistical tests
were undertaken to evaluate potential publication bias in
the reported studies; Egger’s test (p value = 0.001) and
Begg’s test (p value = 0.009) produced statistically significant results. Therefore, published studies on the relationship between serum vitamin D levels and hip fracture are
significantly associated with publication bias, which can
affect the final results of the meta-analysis [75, 76].

Estimation of the relationship between serum
vitamin D levels and hip fractures by considering
the estimated effect size from missing studies
We tried to estimate the effect size for potentially missing
studies within this meta-analysis, as depicted in Fig. 3, it
was estimated that ten studies were missing. Hence, the
analysis performed for this study incorporated and considered the estimated values for those potentially ten missing
studies. Integrating the estimates OR from the ten missing studies into the analysis, the OR of the relationship
between serum vitamin D levels and hip fracture occurrence was equal to 1.40 (95% CI 1.20–1.63 P ≤ 0.001).

Snellman [63]

Steingrimsdottir [64]

Bunchebner [62]

Looker [61]

Kauppi [60]

De Koning [72]

Holvik [49]

Barbour [57]

Cauley [48]
Nakano [71]
Chan [55]
Robinson [56]
Rouzi [59]
de Boer [58]

Bolland [54]

Looker [53]

Cauley [70]

Bakhtiyarova [68]

Sakuma [69]

Cummings [52]

Diamond [67]

Case–control

Fracture ascertainment

Verified medical and
radiological records
1998 USA
Cohort
Verified radiological
records
2006 Japan
Case–control
Verified radiological
records
2006 Russia
Case–control
Verified radiological
records
2008 USA
Nested case–control Verified radiological
records
2008 USA
Cohort
Verified medical and
radiological records
2009 New Zealand Cohort
Verified medical and
radiological records
2010 USA
Case–cohort
Verified medical records
2011 Japan
Case–control
Verified medical records
2011 China
Cohort
Verified medical records
2011 USA
Cohort
Verified medical records
2012 Saudi Arabia Cohort
Verified medical records
2012 USA
Cohort
Verified radiological
records
2012 USA
Cohort
Verified radiological
records
2013 Norway
Case–cohort
Verified medical and
radiological records
2013 Canada
Case–control
Verified medical and
radiological records
2013 Finland
Cohort
Identified National
Hospital
Discharge Register
2013 USA
Cohort
Verified medical and
radiological records
2014 Sweden
Cohort
Verified medical and
radiological records
2014 Iceland
Cohort
Verified medical and
radiological records
2014 Sweden
Cohort
Verified medical and
radiological records

1998 Australia

Publication lead author Year Study setting Study design

˃ 10 µg/d

˃ 20 ng/mL

˃ 20 ng/mL

61 433

5471

1044

4749

3305

Per SD decrease
˃ 30 ng/mL

2656

2526

2614

1929
147
712
2249
707
1621

˃ 70 nmol/L

˃ 17 ng/mL

˃ 18 ng/mL

˃ 20 ng/mL
˃ 10 ng/mL
˃ 25 ng/mL
˃ 15 ng/mL
˃ 18 nmol/L
˃ 20 ng/ml

1917

˃ 30 ng/mL
Per SD decrease
˃ 50 nmol/L
1471

800

164

85

878

123

3871

261

130

287

95

254

1162

84

81
99
24
242
62
17

22

156

400

64

85

133

41
1986–8

1997

(1.06, 5.24)
(1.46, 11.35)
(0.34, 7.38)
(1.11, 2.33)
(1.05, 2.53)
(0.97, 1.86)

1.27 (1.02, 1.57)

2.24 (1.62, 3.10)

2.70 (1.37, 5.33)

2.63 (1.58, 4.37)

1.67 (1.16, 2.40)

1.12 (0.93, 1.35)

1.34 (1.05, 1.70)

1.73 (0.79, 3.81)

2.36
4.07
1.58
1.61
1.63
1.34

1.00 (0.40, 2.50)

2.40 (1.55, 3.71)

1.33 (1.05, 1.68)

2.06 (1.00, 4.24)

1990–2009

2002–6

1995–9

2000–4

2000–1

2007–11

1994–2001

1997–9

2000–2
2010
2001–3
1989–2009
2004–10
1992–2006

1998–2003

1988–94

2004

2002–3

228

64

157

48

12

55

127

24

63
6
48
156
62
132

60

79

85

12

12

24

12

Study period Followup
(months)

7.01 (2.56, 19.23) 2004

2.10 (1.22, 3.63)

3.90 (1.71, 8.91)

Sample size N of Hip *RR 95% CI
fractures

˃ 20 ng/ml

˃ 20 ng/ml

˃ 20 ng/ml

˃ 19 ng/mL

˃50 nmol

25(OH) vitamin
D( Reference
value)

Table 1  Characteristics of included studies for reviewing the relationship between serum vitamin D levels and the risk of hip fractures in the elderly

9

8

8

7

6

6

8

9

8
6
8
8
7
7

7

7

9

6

7

7

8

NOS
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6

A subgroup analysis was performed to determine the association between serum vitamin D levels and hip fractures
based on study design, gender, sample size, follow-up
period, study period, NOS score, and geographical location. The OR of hip fractures in those with a low serum
vitamin D level was (OR = 2.16, 95% CI 1.49–3.11,
P ≤ 0.001) in case–control studies; it was (OR = 1.52, 95%
CI 1.29–1.79, P ≤ 0.001) in cohort studies; and (OR = 1.41,
95% CI = 1.18–1.70, P ≤ 0.001) in case–cohort. The results
of subgroup analysis for geographical location, gender, study
period, article quality according to Newcastle–Ottawa Scale
(NOS) score, sample size, and length of follow-up period are
observable in Table 3.

4.46 (1.55, 12.85) 2015–18

Discussion

Adjusted RR (The adjusted variables in each study can be seen in Table 2)
*

Retrospective
2020 China
[74]Zhuang

˃ 30 ng/mL

525

135

41

8
173
1.67 (1.10, 2,54)
Cohort
2019 Australia
Zhu [66]

˃ 50 nmol/L

1348

143

1998–2013

8
100
1.37 (1.14, 1.64)
Case–cohort
2018 USA
Ginsberg [51]

˃ 20 ng/mL

890

289

1989–2006

8
84
1.09 (0.83, 1.42)
Cohort
2016 Norway
Finnes [65]

˃ 50 nmol/l

21,774

1090

1994–2001

6
Case–control
2016 Brazil
Guerra [14]

˃ 30 ng/mL

341

2013–15
2.76 (1.66, 4.58)
110

28

7
23
2000–2
1.99 (1.18, 3.36)
81
Case–cohort
2015 USA
Swanson [50]

˃ 51.60 pg/mL

1000

2012–14

Verified medical and
radiological records
Verified radiological
records
Verified radiological
records
Verified radiological
records
Verified radiological
records
Verified radiological
records
Verified medical and
radiological records
2015 China
Fu [73]

13

Case–control

Fracture ascertainment

˃ 50 nmol/L

698

349

3.02 (2.12, 4.30)

23

7

Subgroup analysis

Publication lead author Year Study setting Study design

Table 1  (continued)

25(OH) vitamin
D( Reference
value)

Sample size N of Hip *RR 95% CI
fractures

Study period Followup
(months)

NOS

546

This study used systematic and meta-analysis review methodology to investigate a potential association between
25(OH)D levels and the risk of hip fracture in the elderly.
This in-depth analysis concluded that serum vitamin D levels were associated with the risk of hip fractures. Therefore,
the risk of hip fracture is higher in the elderly when they
have insufficient or low levels of serum 25(OH)D levels
(OR = 1.80, 95% CI 1.56–2.07, P ≤ 0.001). Also, Modified OR (considering the effect size for missing studies) of
the relationship between serum vitamin D levels and hip
fracture occurrence was equal to 1.40 (95% CI 1.20–1.63
P ≤ 0.001). In line with the results of the present study,
Feng et al. showed that low serum 25(OH) vitamin D level
was significantly associated with the increased risk of
hip fractures (RR 1.48, 95% CI 1.29–1.68). For each SD
decrease in serum 25(OH) vitamin D level (RR 1.40, 95%
CI 1.20–1.61; I 2 = 0%, p for heterogeneity = 0.51), there was
seen an increase by 40% in the hip fracture risk [25]. In Feng
et al. study, which was conducted in 2017, 19 records were
included. But in the present meta-analysis, 28 articles were
analyzed and similar results were obtained in both our study
and Feng et al. study [25]. In a study conducted by Lv et al.,
in a systematic review and meta-analysis, it was stated that
the relative risk (RR) of the lowest vs. the highest categories indicated that lower levels of serum 25OHD were more
likely to be a risk factor for hip fracture with RR equal to
1.58 (95% CI 1.41–1.77) [77]. The results of this study are
somewhat similar to the results of our study because in our
study the estimated odds ratio of hip fractures is equal to
1.80 (95% CI 1.56–2.07). However, when the effect size in
missing studies is estimated and entered into the analysis, it
is observed that the numerical value of the calculated effect
size decreased. In our study, after considering the effect size
of the missing studies, the calculated odds ratio is equal to
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Table 2  Adjusted variables in assessment relationship between serum vitamin D levels and the risk of hip fractures in the elderly
Publication lead author Year Adjusted variables
Diamond [67]
Sakuma [69]
Bakhtiyarova [68]
Cauley [70]

1998
2006
2006
2008

Looker [53]

2008

Bolland [54]
Cauley [48]
Nakano [71]
Chan [55]
Robinson [56]

2009
2010
2011
2011
2011

Rouzi [59]
de Boer [58]
Barbour [57]

2012
2012
2012

Cummings [52]
Holvik [49]
De Koning [72]
Kauppi [60]
Looker [61]
Bunchebner [62]
Steingrimsdottir [64]
Snellman [63]
Fu [73]

1998
2013
2013
2013
2013
2014
2014
2014
2015

Swanson [50]
Guerra [14]
Finnes [65]
Ginsberg [51]

2015
2016
2016
2018

Zhu [66]

2019

Zhuang [74]

2020

Age, body weight, comorbid illnesses, alcohol intake, cigarettes smoked, and corticosteroid use
–
–
Age, body mass index, parental history of hip fracture, history of fracture, smoking, alcohol use, and total calcium intake, oral corticosteroid use, and geographic region
Age, sex, femoral neck BMD, BMI, previous fracture, dietary calcium, kilocalories, and weight loss from maximum
Treatment allocation (calcium or placebo) and baseline age, body weight, and smoking status
Age, race, clinic, the season of blood draw, physical activity, weight, and height
Sex, circulating concentrations of albumin, hemoglobin, 25OH-D, PK, and MK7
Age, BMI, education, PASE, DQI, smoking status, and alcohol use
Age, race, sex, clinic site, season, education, smoking status (never smoker, former smoker, or current smoker),
alcohol use (any vs. none), diabetes status (normal, impaired fasting glucose, or diabetes), body mass index,
self-reported health status, physical activity level, oral steroid use, estrogen use, thiamine and loop diuretic use,
serum cystatin C level, and calcium supplement use
–
Age, sex, clinical site, smoking, body mass index, and physical activity
Age, gender, race, education level, the season of blood draw, BMI, current drinking, fracture after age 45, and
clinical comorbidity index
Age and weight
Age, gender, study center, BMI, and month of blood sample
Sex and age
Gender, age, height, weight, BMI, QU, alcohol consumption, smoking, and PA
Age, sex, race/ethnicity, and survey
Smoking, bisphosphonate use, and physical activity level
Age, sex, body mass index, height, smoking, alcohol intake and season, physical activity
Age, weight, height, and season
Age, inadequate sun exposure, history of falls during the last year, neurologic impairment, cognitive impairment,
and serum levels of Hs-CRP, ALP, and iPTH
–
Sex, age, and ethnicity
Age, sex, study site, BMI, smoking, triglycerides, and α-tocopherol
Age, sex, race, the season of measurements, site of measurement and BMI, eGFR, serum calcium, phosphate,
and FGF-23
Season of blood sampling to baseline age and BMI, treatment group during the intervention phase, and fracture
history
Age, serum 25OHD levels, one mineral density, and BMI

1.40 (95% CI 1.20–1.63). Therefore, we think that in the
systematic review and meta-analysis study that conducted
by Lv et al., due to publication bias, most studies have been
considered that the results of which confirm the increased
risk of hip fractures due to deficiency in serum levels of vitamin D, and finally the result obtained in this meta-analysis
is overestimated [77].
In another systematic review and meta-analysis study
conducted by Lai et al., the RR of hip fractures was equal
to 1.13[95% CI 0.98–1.29] based on seven eligible randomized controlled trials (RCT) studies [27]. Although this
study confirms the increased relative risk of hip fractures
in individuals receiving lower doses of vitamin D, it is not

statistically significant. It seems that the smaller sample size
of the studies considered in this meta-analysis has negative
effects on its results, because often in clinical trial studies
the number of subjects and their follow-up time is limited,
although the results of these studies have more credibility.
In addition, in another systematic review and meta-analysis study conducted with Wang et al., the study was performed using reported serum 25(OH)D levels from 3237
patients who were > 60 years of age and had experienced
a hip fracture. The study showed that low serum 25(OH)
D levels increase the risk of hip fracture when compared to
those who have high serum 25(OH)D levels 1.12 (95% CI
1.02–1.25) after adjustments [78]. As can be seen, different
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study_author

year

Caummings
1998
De Koning
2013
Barbour
2012
Looker
2013
Tetsuo Nakano
2011
Swanson
2015
Fu
2015
Chan
2011
Sakuma
2006
Bakhtiyarova
2006
Hua-feng Zhuang 2020
Kauppi
2013
Guerra
2016
Diamond
1998
Ginsberg
2018
Snellman
2014
Looker
2008
Bolland
2009
Steingrimsdottir
2014
Finnes
2016
Holvik
2013
Robinson
2011
Kun Zhu
2019
Rouzi
2012
Cauley
2010
Cauley
2008
Bunchebner
2014
de Boer
2012
Overall (I-squared = 68.8%, p = 0.000)

ES (95% CI)

%
Weight

2.10 (1.22, 3.63)
1.12 (0.93, 1.35)
1.73 (0.79, 3.81)
2.63 (1.58, 4.37)
4.07 (1.46, 11.35)
1.99 (1.18, 3.36)
3.02 (2.12, 4.30)
1.58 (0.34, 7.38)
7.01 (2.56, 19.23)
2.06 (1.00, 4.24)
4.46 (1.55, 12.85)
1.67 (1.16, 2.40)
2.76 (1.66, 4.58)
3.90 (1.71, 8.91)
1.37 (1.14, 1.64)
1.27 (1.02, 1.57)
2.40 (1.55, 3.71)
1.00 (0.40, 2.50)
2.24 (1.62, 3.10)
1.09 (0.83, 1.42)
1.34 (1.05, 1.71)
1.61 (1.11, 2.33)
1.67 (1.10, 2.54)
1.63 (1.05, 2.53)
2.36 (1.06, 5.24)
1.33 (1.05, 1.68)
2.70 (1.37, 5.33)
1.34 (0.97, 1.86)
1.80 (1.56, 2.07)

3.26
5.81
2.11
3.50
1.44
3.38
4.58
0.73
1.48
2.37
1.37
4.49
3.50
1.98
5.85
5.62
3.98
1.72
4.79
5.24
5.40
4.44
4.09
3.95
2.08
5.48
2.56
4.79
100.00

NOTE: Weights are from random effects analysis
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Fig. 2  Overall analysis of serum vitamin D levels and the risk of hip fractures
Fig. 3  Estimation of the amount
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Table 3  Subgroup analysis of
the association between serum
vitamin D levels and the risk of
hip fractures in the elderly
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Characteristics
Study type

Study location

Gender

Study period
Follow-up period
Newcastle–Ottawa scale
Sample size

Study no
Case–cohort
Cohort
Case–control
North America
Europe
Asia
Australia and New Zealand
Brazil
Male
Female
Both
1980–2009
2010–2021
less than five years
More than five years
Good
Excellent
> 1000
≤ 1000

studies show different effect sizes of low serum levels of
vitamin D on hip fractures, which seems to be one of the
most important reasons for this difference in addition to the
age groups studied in each meta-analysis, is lack of considering the effect of publication bias on the results.
Previous meta-analyses conducted in this regard have
assessed the effect of vitamin D supplementation in conjunction with hip fractures. However, there has been no
consensus reached, and different results have been reported.
For instance, Bischoff-Ferrari et al. [79] suggested that the
effect was positive on hip and any non-vertebral fractures.
In contrast, Lai et al. reported that varying doses of vitamin D supplementation were effective in preventing a hip
fracture [27]. Another meta-analysis indicated that vitamin
D supplementation in the elderly had no effect on hip bone
mineral density (BMD) and that its effect on femur BMD
was low [80]. These discrepancies in study results may be
caused by differences in the methods of studies undertaken,
varying characteristics in bone compartments (cortical or
trabecular-rich sites), and other potentially confounding
factors. The hip bone is considered a cortical site and is
generally less responsive to vitamin supplementation than
other trabecular-rich sites (e.g., pelvis, femoral neck, and
calcaneus) [80–83]. These already established associations
support the need for more studies to determine the interaction or synergistic effects of micronutrients on the proper
mineralization of bone for optimal skeletal health.
Consequently, it seems that normal serum 25(OH)D levels can benefit bone health when considering its interaction
with other biochemical factors, which provide a protective

4
15
9
11
6
7
3
1
4
9
15
7
21
14
14
14
14
13
15

OR (95% CI)
1.41(1.18–1.70)
1.52(1.29–1.79)
2.16(1.49–3.11)
1.59(1.35–1.88)
1.44(1.14–1.82)
2.76(1.89–4.02)
1.86(0.97–3.56)
2.76(1.68–4.53)
2.34(1.60–3.41)
1.87(1.45–2.40)
1.31(1.01–1.62)
1.34(1.13–1.58)
2.16(1.45–3.22)
2.17(1.63–2.89)
1.41(1.23–1.62)
1.86(1.44–2.40)
1.34(1.14–1.57)
1.98(1.54–2.54)
1.41(1.20–1.65)

P value
≤ 0.001
≤ 0.001
≤ 0.001
≤ 0.001
≤ 0.001
≤ 0.001
0.059
≤ 0.001
≤ 0.001
≤ 0.001
≤ 0.001
≤ 0.001
≤ 0.001
≤ 0.001
≤ 0.001
≤ 0.001
≤ 0.001
≤ 0.001
≤ 0.001

effect against bone fractures. It has been established that
minerals including calcium, phosphorus, fluoride, magnesium, copper, iron, selenium, zinc, manganese, sodium,
potassium, and vitamins including D, A, K, C, B6, B12, in
addition to folate, play a crucial role in bone health [84–88].
Compared to previously published studies, this study calculated that the OR of hip fractures was different based on
geographical locations. The rationale for this is that lifestyle,
diet, and race can affect vitamin D levels and, therefore,
the risk of hip fractures. Muñoz-Garach et al. reported that
80–90% of vitamin D is supplied from cutaneous synthesis
from exposure to sunlight, while the remaining 10–20% is
obtained from a limited number of foods, such as fortified
foods, oily fish, and mushrooms [85]. Therefore, the geographical region and consequently vitamin D serum levels
are affected by sunlight, culture, and diet. These already
established associations support the need for more studies
to determine the interaction or synergistic effects of micronutrients on the proper mineralization of bone for optimal
skeletal health. Additionally, encouraging the development
of education programs that could inform the elderly regarding the need to monitor and increase vitamin D levels could
improve health outcomes.
This systematic and meta-analysis study involved a comprehensive and complete search of the articles related to the
topic. Statistical tools were used to estimate the effect size
of missing studies and assess the influence of subgroups on
the strengths of the reviewed article. In addition, one of the
most important strengths of this study is the calculation of
the modified OR by estimating the effect size of missing
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studies (due to diffusion bias), so it seems that considering
the impact of missing studies, the estimated OR is more
reliable. The inclusion of only English-language articles
is a potential limitation of this study. In addition, lack of
access to some databases such as EMBASE and Cochrane
was another limitation of this study. Because in the analysis of subgroups, the results of the study are presented specifically for specific geographical areas, we must be careful about generalizing the results, especially in areas where
the number of studies included in the meta-analysis (Brazil, Australia and, New Zealand) is small. Also, although
this systematic review and meta-analysis study specifically
assessed the association between serum vitamin D levels and
hip fractures in the elderly, the results of it can be attributed
to other age groups, but it is better to do similar studies in the
desired age groups. The development of low serum 25(OH)
D levels, especially in the elderly, significantly increases the
risk of a hip fracture being incurred. Vitamin D deficiency
is a significant health issue given that it increases the risk of
osteoporosis, hip fracture and causes other health complications that have a significant impact on the quality of life.
The conclusions from this study support encouraging the
monitoring of serum 25(OH)D levels at appropriate intervals
during age progression to reduce the risk of hip fractures in
the elderly.
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